Michael Harsh - Jan 3, 2022 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Michael Harsh by Mark Busch, attorney-in-fact
Stock symbol
NDRA
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2022, 04:05 PM
Next filing
Mar 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NDRA Stock Options Award $0 +12K $0.00 12K Jan 3, 2022 Common Stock 12K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy.